Supriya Lifescience Status Update on Pending Judicial Proceedings Involving GM of Sales
Supriya Lifescience Ltd 路 Others (Uncategorized) 路 02 Sept 2026, 11:02 pm
Supriya Lifescience Status Update on Pending Judicial Proceedings Involving GM of Sales Supriya Lifescience reported on 2nd Sep'25 that ongoing judicial proceedings involving its General Manager of Sales & Marketing remain sub judice, awaiting court hearing and adjudication. Currently, there are no new developments or court orders regarding the matter. The company previously communicated the case status during its August earnings call and reiterated its commitment to monitoring the situation. Management confirms it will notify stock exchanges immediately upon receiving any material updates or regulatory orders from the court.
Original exchange filing (PDF)
More announcements from Supriya Lifescience Ltd
- Earnings Call Transcript is enclosed herewith. 路 13 Nov 2026
- Outcome of the Results Earning Call for Quarter and Half year ended September 30, 2026 is enclosed herewith. 路 07 Nov 2026
- Press Release is enclosed herewith. 路 07 Nov 2026
- Investor Presentation is enclosed for the Results Earnings Call for quarter and half year ended September 30, 2026. 路 06 Nov 2026
- Change In Management - Appointment of Senior Management Personnel of the Company. 路 06 Nov 2026
- Please find enclosed. 路 06 Nov 2026
- Supriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 06 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held .... 路 06 Nov 2026
